Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been recognized as a classical glycolytic protein and has been used as a “housekeeping” gene in studies of genetic expression and regulation. However, recent advances reveal that GAPDH displays diverse nonglycolytic functions depending on its...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Progress in neuro-psychopharmacology & biological psychiatry 2003-04, Vol.27 (2), p.291-301
Hauptverfasser: Ishitani, Ryoichi, Tajima, Hisao, Takata, Hiroyuki, Tsuchiya, Katsumi, Kuwae, Toyoyasu, Yamada, Mitsunori, Takahashi, Hitoshi, Tatton, Nadine A., Katsube, Nobuo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 301
container_issue 2
container_start_page 291
container_title Progress in neuro-psychopharmacology & biological psychiatry
container_volume 27
creator Ishitani, Ryoichi
Tajima, Hisao
Takata, Hiroyuki
Tsuchiya, Katsumi
Kuwae, Toyoyasu
Yamada, Mitsunori
Takahashi, Hitoshi
Tatton, Nadine A.
Katsube, Nobuo
description Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been recognized as a classical glycolytic protein and has been used as a “housekeeping” gene in studies of genetic expression and regulation. However, recent advances reveal that GAPDH displays diverse nonglycolytic functions depending on its subcellular localization. Among those functions, one of the most intriguing is likely to be the induction of apoptosis. Previous works by our group and others have demonstrated that the overexpression of GAPDH and its subsequent nuclear translocation appear to be implicated in the initiation of one or more apoptotic cascades and also in the etiology of some neurological diseases. This review addresses new data demonstrating that a protein, referred to as proapoptotic protein GAPDH, with a quite mundane function in healthy cells behaves very differently during cell suicide, and summarizes emphatically the importance of this protein as a putative molecular target in developing antiapoptotic therapeutic agents for the treatment of certain neurodegenerative disorders.
doi_str_mv 10.1016/S0278-5846(03)00024-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73137355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0278584603000241</els_id><sourcerecordid>73137355</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-1890eb6a370e1bf730c2ec224a1d6fc16c8c9fa2747b1e2c53163aca0a9cdc2d3</originalsourceid><addsrcrecordid>eNqFkM-v0zAMgCME4o0HfwKoFxAcCnHSJh0XhJ74JT0JJOAcua67BXVNSTKk_ffkbRM7crLlfLbjT4inIF-DBPPmu1S2q9uuMS-lfiWlVE0N98QKulJuFJj7YvUPuRKPUvpVINBSPxRXoExrtelWInyLAZew5JA9VUsMmf1cbaYDccRp4O1h4FrXyzakZYuZq2Mphg3PmPhthdUSUvL9xFXy5TmMFVL2YT5mc_aX4UPcb9Jj8WDEKfGTc7wWPz9--HHzub79-unLzfvbmprW5hq6teTeoLaSoR-tlqSYlGoQBjMSGOpoPaKyje2BFbUajEZCiWsaSA36Wrw4zS0n_d5zym7nE_E04cxhn5zVoK1u2wK2J5BiOSTy6JbodxgPDqS7M-2Opt2dRie1O5p2UPqenRfs-x0Pl66z2gI8PwOYCKcx4kw-XbjGgAVjC_fuxHHR8cdzdIk8z8SDj0zZDcH_5yt_AeGYnTM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73137355</pqid></control><display><type>article</type><title>Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ishitani, Ryoichi ; Tajima, Hisao ; Takata, Hiroyuki ; Tsuchiya, Katsumi ; Kuwae, Toyoyasu ; Yamada, Mitsunori ; Takahashi, Hitoshi ; Tatton, Nadine A. ; Katsube, Nobuo</creator><creatorcontrib>Ishitani, Ryoichi ; Tajima, Hisao ; Takata, Hiroyuki ; Tsuchiya, Katsumi ; Kuwae, Toyoyasu ; Yamada, Mitsunori ; Takahashi, Hitoshi ; Tatton, Nadine A. ; Katsube, Nobuo</creatorcontrib><description>Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been recognized as a classical glycolytic protein and has been used as a “housekeeping” gene in studies of genetic expression and regulation. However, recent advances reveal that GAPDH displays diverse nonglycolytic functions depending on its subcellular localization. Among those functions, one of the most intriguing is likely to be the induction of apoptosis. Previous works by our group and others have demonstrated that the overexpression of GAPDH and its subsequent nuclear translocation appear to be implicated in the initiation of one or more apoptotic cascades and also in the etiology of some neurological diseases. This review addresses new data demonstrating that a protein, referred to as proapoptotic protein GAPDH, with a quite mundane function in healthy cells behaves very differently during cell suicide, and summarizes emphatically the importance of this protein as a putative molecular target in developing antiapoptotic therapeutic agents for the treatment of certain neurodegenerative disorders.</description><identifier>ISSN: 0278-5846</identifier><identifier>EISSN: 1878-4216</identifier><identifier>DOI: 10.1016/S0278-5846(03)00024-1</identifier><identifier>PMID: 12657368</identifier><identifier>CODEN: PNPPD7</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Ageing, cell death ; Aggregate formation ; Amino Acid Sequence ; Animals ; Antiapoptotic drugs ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - physiology ; Biological and medical sciences ; Cell Nucleus - metabolism ; Cell physiology ; DNA, Complementary - biosynthesis ; DNA, Complementary - genetics ; Functional domains ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic - genetics ; Gene Expression Regulation, Enzymologic - physiology ; Glyceraldehyde-3-phosphate dehydrogenase ; Glyceraldehyde-3-Phosphate Dehydrogenases - drug effects ; Glyceraldehyde-3-Phosphate Dehydrogenases - genetics ; Glyceraldehyde-3-Phosphate Dehydrogenases - physiology ; Humans ; Molecular and cellular biology ; Molecular Sequence Data ; Neurodegenerative disorders ; Nuclear translocation ; Pathogenesis ; Promoter region</subject><ispartof>Progress in neuro-psychopharmacology &amp; biological psychiatry, 2003-04, Vol.27 (2), p.291-301</ispartof><rights>2003 Elsevier Science Inc.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-1890eb6a370e1bf730c2ec224a1d6fc16c8c9fa2747b1e2c53163aca0a9cdc2d3</citedby><cites>FETCH-LOGICAL-c457t-1890eb6a370e1bf730c2ec224a1d6fc16c8c9fa2747b1e2c53163aca0a9cdc2d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0278584603000241$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14617167$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12657368$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishitani, Ryoichi</creatorcontrib><creatorcontrib>Tajima, Hisao</creatorcontrib><creatorcontrib>Takata, Hiroyuki</creatorcontrib><creatorcontrib>Tsuchiya, Katsumi</creatorcontrib><creatorcontrib>Kuwae, Toyoyasu</creatorcontrib><creatorcontrib>Yamada, Mitsunori</creatorcontrib><creatorcontrib>Takahashi, Hitoshi</creatorcontrib><creatorcontrib>Tatton, Nadine A.</creatorcontrib><creatorcontrib>Katsube, Nobuo</creatorcontrib><title>Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs</title><title>Progress in neuro-psychopharmacology &amp; biological psychiatry</title><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><description>Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been recognized as a classical glycolytic protein and has been used as a “housekeeping” gene in studies of genetic expression and regulation. However, recent advances reveal that GAPDH displays diverse nonglycolytic functions depending on its subcellular localization. Among those functions, one of the most intriguing is likely to be the induction of apoptosis. Previous works by our group and others have demonstrated that the overexpression of GAPDH and its subsequent nuclear translocation appear to be implicated in the initiation of one or more apoptotic cascades and also in the etiology of some neurological diseases. This review addresses new data demonstrating that a protein, referred to as proapoptotic protein GAPDH, with a quite mundane function in healthy cells behaves very differently during cell suicide, and summarizes emphatically the importance of this protein as a putative molecular target in developing antiapoptotic therapeutic agents for the treatment of certain neurodegenerative disorders.</description><subject>Ageing, cell death</subject><subject>Aggregate formation</subject><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Antiapoptotic drugs</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - physiology</subject><subject>Biological and medical sciences</subject><subject>Cell Nucleus - metabolism</subject><subject>Cell physiology</subject><subject>DNA, Complementary - biosynthesis</subject><subject>DNA, Complementary - genetics</subject><subject>Functional domains</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic - genetics</subject><subject>Gene Expression Regulation, Enzymologic - physiology</subject><subject>Glyceraldehyde-3-phosphate dehydrogenase</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - drug effects</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - genetics</subject><subject>Glyceraldehyde-3-Phosphate Dehydrogenases - physiology</subject><subject>Humans</subject><subject>Molecular and cellular biology</subject><subject>Molecular Sequence Data</subject><subject>Neurodegenerative disorders</subject><subject>Nuclear translocation</subject><subject>Pathogenesis</subject><subject>Promoter region</subject><issn>0278-5846</issn><issn>1878-4216</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM-v0zAMgCME4o0HfwKoFxAcCnHSJh0XhJ74JT0JJOAcua67BXVNSTKk_ffkbRM7crLlfLbjT4inIF-DBPPmu1S2q9uuMS-lfiWlVE0N98QKulJuFJj7YvUPuRKPUvpVINBSPxRXoExrtelWInyLAZew5JA9VUsMmf1cbaYDccRp4O1h4FrXyzakZYuZq2Mphg3PmPhthdUSUvL9xFXy5TmMFVL2YT5mc_aX4UPcb9Jj8WDEKfGTc7wWPz9--HHzub79-unLzfvbmprW5hq6teTeoLaSoR-tlqSYlGoQBjMSGOpoPaKyje2BFbUajEZCiWsaSA36Wrw4zS0n_d5zym7nE_E04cxhn5zVoK1u2wK2J5BiOSTy6JbodxgPDqS7M-2Opt2dRie1O5p2UPqenRfs-x0Pl66z2gI8PwOYCKcx4kw-XbjGgAVjC_fuxHHR8cdzdIk8z8SDj0zZDcH_5yt_AeGYnTM</recordid><startdate>20030401</startdate><enddate>20030401</enddate><creator>Ishitani, Ryoichi</creator><creator>Tajima, Hisao</creator><creator>Takata, Hiroyuki</creator><creator>Tsuchiya, Katsumi</creator><creator>Kuwae, Toyoyasu</creator><creator>Yamada, Mitsunori</creator><creator>Takahashi, Hitoshi</creator><creator>Tatton, Nadine A.</creator><creator>Katsube, Nobuo</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030401</creationdate><title>Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs</title><author>Ishitani, Ryoichi ; Tajima, Hisao ; Takata, Hiroyuki ; Tsuchiya, Katsumi ; Kuwae, Toyoyasu ; Yamada, Mitsunori ; Takahashi, Hitoshi ; Tatton, Nadine A. ; Katsube, Nobuo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-1890eb6a370e1bf730c2ec224a1d6fc16c8c9fa2747b1e2c53163aca0a9cdc2d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Ageing, cell death</topic><topic>Aggregate formation</topic><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Antiapoptotic drugs</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - physiology</topic><topic>Biological and medical sciences</topic><topic>Cell Nucleus - metabolism</topic><topic>Cell physiology</topic><topic>DNA, Complementary - biosynthesis</topic><topic>DNA, Complementary - genetics</topic><topic>Functional domains</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic - genetics</topic><topic>Gene Expression Regulation, Enzymologic - physiology</topic><topic>Glyceraldehyde-3-phosphate dehydrogenase</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - drug effects</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - genetics</topic><topic>Glyceraldehyde-3-Phosphate Dehydrogenases - physiology</topic><topic>Humans</topic><topic>Molecular and cellular biology</topic><topic>Molecular Sequence Data</topic><topic>Neurodegenerative disorders</topic><topic>Nuclear translocation</topic><topic>Pathogenesis</topic><topic>Promoter region</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishitani, Ryoichi</creatorcontrib><creatorcontrib>Tajima, Hisao</creatorcontrib><creatorcontrib>Takata, Hiroyuki</creatorcontrib><creatorcontrib>Tsuchiya, Katsumi</creatorcontrib><creatorcontrib>Kuwae, Toyoyasu</creatorcontrib><creatorcontrib>Yamada, Mitsunori</creatorcontrib><creatorcontrib>Takahashi, Hitoshi</creatorcontrib><creatorcontrib>Tatton, Nadine A.</creatorcontrib><creatorcontrib>Katsube, Nobuo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishitani, Ryoichi</au><au>Tajima, Hisao</au><au>Takata, Hiroyuki</au><au>Tsuchiya, Katsumi</au><au>Kuwae, Toyoyasu</au><au>Yamada, Mitsunori</au><au>Takahashi, Hitoshi</au><au>Tatton, Nadine A.</au><au>Katsube, Nobuo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs</atitle><jtitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</jtitle><addtitle>Prog Neuropsychopharmacol Biol Psychiatry</addtitle><date>2003-04-01</date><risdate>2003</risdate><volume>27</volume><issue>2</issue><spage>291</spage><epage>301</epage><pages>291-301</pages><issn>0278-5846</issn><eissn>1878-4216</eissn><coden>PNPPD7</coden><abstract>Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has long been recognized as a classical glycolytic protein and has been used as a “housekeeping” gene in studies of genetic expression and regulation. However, recent advances reveal that GAPDH displays diverse nonglycolytic functions depending on its subcellular localization. Among those functions, one of the most intriguing is likely to be the induction of apoptosis. Previous works by our group and others have demonstrated that the overexpression of GAPDH and its subsequent nuclear translocation appear to be implicated in the initiation of one or more apoptotic cascades and also in the etiology of some neurological diseases. This review addresses new data demonstrating that a protein, referred to as proapoptotic protein GAPDH, with a quite mundane function in healthy cells behaves very differently during cell suicide, and summarizes emphatically the importance of this protein as a putative molecular target in developing antiapoptotic therapeutic agents for the treatment of certain neurodegenerative disorders.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>12657368</pmid><doi>10.1016/S0278-5846(03)00024-1</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0278-5846
ispartof Progress in neuro-psychopharmacology & biological psychiatry, 2003-04, Vol.27 (2), p.291-301
issn 0278-5846
1878-4216
language eng
recordid cdi_proquest_miscellaneous_73137355
source MEDLINE; Elsevier ScienceDirect Journals
subjects Ageing, cell death
Aggregate formation
Amino Acid Sequence
Animals
Antiapoptotic drugs
Apoptosis
Apoptosis - drug effects
Apoptosis - physiology
Biological and medical sciences
Cell Nucleus - metabolism
Cell physiology
DNA, Complementary - biosynthesis
DNA, Complementary - genetics
Functional domains
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Enzymologic - genetics
Gene Expression Regulation, Enzymologic - physiology
Glyceraldehyde-3-phosphate dehydrogenase
Glyceraldehyde-3-Phosphate Dehydrogenases - drug effects
Glyceraldehyde-3-Phosphate Dehydrogenases - genetics
Glyceraldehyde-3-Phosphate Dehydrogenases - physiology
Humans
Molecular and cellular biology
Molecular Sequence Data
Neurodegenerative disorders
Nuclear translocation
Pathogenesis
Promoter region
title Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T01%3A40%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proapoptotic%20protein%20glyceraldehyde-3-phosphate%20dehydrogenase:%20a%20possible%20site%20of%20action%20of%20antiapoptotic%20drugs&rft.jtitle=Progress%20in%20neuro-psychopharmacology%20&%20biological%20psychiatry&rft.au=Ishitani,%20Ryoichi&rft.date=2003-04-01&rft.volume=27&rft.issue=2&rft.spage=291&rft.epage=301&rft.pages=291-301&rft.issn=0278-5846&rft.eissn=1878-4216&rft.coden=PNPPD7&rft_id=info:doi/10.1016/S0278-5846(03)00024-1&rft_dat=%3Cproquest_cross%3E73137355%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73137355&rft_id=info:pmid/12657368&rft_els_id=S0278584603000241&rfr_iscdi=true